Добавил:
kiopkiopkiop18@yandex.ru Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

4 курс / Акушерство и гинекология / Егорова_Е_С_Основные_принципы_ведения_беременных_с_анемией_и_тромбофилией

.pdf
Скачиваний:
0
Добавлен:
23.03.2024
Размер:
2.69 Mб
Скачать

148.NIH: National Institutes of Health, The Sixth Report of the Joint National Committee on Prevention, Detection and Treatment of High Blood Pressure // NIH-Publication, No 98-4080, 1997.

149.Nochy D., Daugas E., Huong D.L.T. et al. Kidney involvement in the antiphospholipid syndrome // Journal of Autoimmunity – 2000. - Vol. 15. - P. 127

– 132.

150. Nossent H. C., Swaak T.J.G. Systemic lupus erythematosus IV: analysis of the interrelationship between pregnancy // J. Rheumatol. – 1990. - Vol. 17. - P. 771

– 776.

151.Ornstein M.H., Rand J.H. An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of two cases // J. Rheumatol. – 1994. - Vol. 21. - P. 1360 – 1364.

152.Ostensen M., Ostensen H. Safety of nonsteroidal anti-inflammatory drugs in pregnant patients with rheumatic diseases // J. Rheumatol. – 1996. - Vol. 23. - P. 1045 – 1049.

153.Out H. J., Kooijman C.D., Bruinse H.W. et al. Histopathological findings in placentae from patients with intrauterine fetal death and antiphospholipid antibodies // Eur. J. Obstet. Gynecol. Reprod. Biol. – 1991. - Vol. 41, № 2. - P. 179

– 186.

154.Pampus M.G., Dekker G.A., Wolf H. et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia // Am. J. Obstet. Gynecol. – 1999. - Vol. 180, № 5. - P. 1146 – 1150.

155.Parke A., West B. Hydroxychloquine in pregnant patients with systemic lupus erythematosus // J. Rheumatol. – 1996. - Vol. 23. - P. 1715 – 1718.

156.Pattison N.S., Chamley L.W., Birdsall M. et al. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial // Am. J. Obstet. Gynecol. – 2000. - Vol. 183, № 4. - P. 1008 – 1012.

153

157.Pauzner R., Dulitzki M., Langevitz P. et al. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy // Thromb. Haemost. – 2001. - Vol. 86. - P. 1379 – 1384.

158.Petri M. Pregnancy in SLE // Bailliere’s Clin. Rheumatol. – 1996. - Vol. 12. - P. 449 – 476.

159.Petri M., Howard D., Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience // Arthritis Rheum. – 1991. - Vol. 34. - P. 1538 – 1545.

160.Rached R.A., Horellou M.H., Elalamy I. et al. Homozygous 20210A prothrombin mutation combined with heterozygous factor V Leiden mutation. Thrombotic consequences in 5 unrelated women // 16th Congress on thrombosis and haemostasis, Porto, May 2000.

161.Rahman P., Gladman D.D., Urowitch M. Clinical predictors for fetal outcome in systemic lupus erythematosus // J. Rheumatol. – 1998. - Vol. 25. - P. 1526 – 1530.

162.Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) // BMJ – 1997. - Vol. 314. - P. 253 – 257.

163.Rand J. H. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome // Journal of Autoimmunity – 2000. - Vol. 15. - P. 107 – 111.

164.Rand J.H., Wu X.X. Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome // Thromb. Haemost. – 1999. - Vol. 82. - P. 649.

165.Rand J.H., Wu X.X., Andree HAM. et al. Pregnancy loss in the antiophspholipid syndrome a possible thrombogenic mechanism // N. Engl. J. Med.

– 1997. - Vol. 337. - P. 154 - 160.

166.Regan L., Rai R. Thrombophilia and pregnancy loss // Journal of

Reproductive Immunology – 2002. - Vol. 55, № 1 – 2. - P. 163 – 180.

154

167.Reichlin M. Systemic lupus erythematosus and pregnancy // J. Reprod. Med. – 1998. - Vol. 43. - P. 355 – 360.

168.Roberts J.M., Lain K.Y. Recent insights into the pathogenesis of preeclampsia // Placenta – 2002. - Vol. 23. - P. 359 – 372.

169.Rosendaal F.R. Risk factors in venous thrombotic disease // Thromb. Haemost. – 1999. - Vol. 82, № 2. - P. 610 – 620.

170.Rosove M.H., Tabsh K., Wasserstrum N. et al. Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies // Obstet. Gynecol. –

1990. - Vol. 75. - P. 630 – 634.

171. Roubenoff R., Hoyt J., Petri M. et al. Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility // Semin. Arthritis Rheum. – 1998. - Vol. 25. - P. 618 – 623.

172.Roubey R.A.S., Eisenberg R.A., Harper M.F., Winfield J.B.

“Anticardiolipin” autoantibodies recognize 2-glycoprotein I in the absence of phospholipid // Journal of Immunology – 1995 - Vol. 154. - P. 954 – 960.

173.Ruiz-Irastorza G., Khamastha M., Hughes G. Treatment of the antiphospholipid syndrome in pregnancy // Scand. J. Rheumatol. – 1998. - Vol.

107.- P. 44 – 47.

174.Ruiz-Irastorza G., Lima F., Alves J. et al. Increased rate of lupus flare during pregnancy and the puerperium // Br. J. Rheumatol. – 1996. - Vol. 35. - P.

133- 138.

175.Schneider D.M., Heilmann L., von Tempelhoff G.-F. et al. Antiphospholipid antibodies and haematological defects in women with a history of preeclampsia/HELLP and outcome of IVIG treated pregnancies // Ann. Hematol. – 1999. - Vol. 78 (suppl 1). - P. 455.

176.Sherer Y., Shoenfeld Y. The idiotypic network in antinuclear-antibody- associated diseases // Int. Arch. Allergy Immunol. – 2000. - Vol. 123. - P. 10 – 15.

177.Shohaib S.A. Reactivation of systemic lupus erythematosus by pregnancy in a hemodialysis patient // Nephron – 1997. - Vol. 77. - P. 238.

155

178.Siaka C., Lambert M., Caron C., Amiral J., Hachulla E., Hatron P.Y., et al. Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss // Rev. Med. Intern. – 1999. - Vol. 20. - P. 762.

179.Silveira L.H., Hubble C.L., Jara L.J. et al. Prevention of anticardiolipin-related pregnancy losses with prednisone and aspirin // Am. J. Med. – 1992. - Vol. 93. - P.

403– 411.

180.Silver R.K., MacGregor S.N., Sholl J.S. et al. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients // Am. J. Obstet. Gynecol. – 1993. - Vol. 169. - P. 1411 – 1417.

181.Spinnato J.A. Clark A.L., Pierangeli S.S. et al. Intravenous immunoglobulin

therapy for the antiphospholipid syndrome in pregnancy // Am. J. Obstet. Gynecol.

– 1995. - Vol. 172. - P. 690 – 694.

182.Toma H., Tanabe K., Tokumoto T. et al. Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide survey of pregnancies on renal replacement therapy in Japan // Nephrol. Dial. Transpl. – 1999. – Vol. 14. - P. 1511 – 1516.

183.Toyota T., Yorioka N., Takahashi N. et al. Successful birth in a hemodialysis patient with SLE // Nephron – 1993. - Vol. 65.- P. 331 – 332.

184.Tseng C.E., Buyon J. Neonatal lupus syndromes // Rheum. Dis. Clin. North. Am. – 1997. - Vol. 23. - P. 31 – 35.

185.VanWijk M.J., Kublickiene K., Boer K., VanBavel E. Vascular function in preeclampsia // Cardiovascular Research – 2000. - Vol. 47. - P. 38 – 48.

186.Wahl D.G., Guillemin F., de Maistre E. et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erytematosus // Lupus –

1997. - Vol. 6. - P. 467 - 473.

187. Wang X., Campos B., Kaetzel M.A., Dedman J.R. Annexin V is critical in the maintenance of murine placental integrity // Am. J. Obstet. Gynecol. – 1999. - Vol. 180, № 4. - P. 1008 – 1016.

156

188.Weitz J.I. Low-molecular-weight heparins // N. Engl. J. Med. – 1997. - Vol.

337.- P. 688 - 698.

189.Welsch S., Branch D.W. Antiphospholipid syndrome in pregnancy // Rheum. Dis. Clin. North. Am. – 1997. - Vol. 23. - P. 71 – 78.

190.Witlin A.G., Mattar F.M., Saade G.R. et al. Presentation of venous thromboembolism during pregnancy // Am. J. Obstet. Gynecol. – 1999. - Vol. 181,

№ 5. - P. 1118 – 1121.

191. World Health Organization. International Society of Hypertension Guidelines for Management of Hypertension // J. Hypertension – 1999. – Vol. 17. - P. 151 – 183.

157